Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

Overview of attention for article published in JACC, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source
twitter: 18 X users
facebook: 2 Facebook pages

googleplus: 2 Google+ users
guideline: 1 clinical guideline source

Readers on

mendeley: 111 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Long-Acting Inhaled Drugs for Chronic Obstructive Pulmonary Disease - List of Included Studies

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 29 May 2025

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.